Jabra Enhance Pro 20 at Costco vs Signia Pure C&G IX

The Jabra Enhance Pro 20 at Costco is a prescription behind-the-ear hearing aid available for $1,600, earning an A grade with a SoundScore of 4.0/5 in our lab testing. This places it in the top 61% of the 36 prescription hearing aids we've evaluated. In our testing, this device shows a mixed performance profile. Own-voice comfort is a clear strength, scoring 3.5/5—0.75 points above the category average—making it a solid choice for users who prioritize natural sound quality when speaking. Feedback handling is excellent at 4.8/5, slightly above the category average, indicating stable performance during typical daily activities. However, speech-in-noise performance is notably limited, scoring just 1.1/5—0.82 points below the category average of 1.96. This is a meaningful weakness for users who frequently encounter noisy environments like restaurants or social gatherings. Speech in quiet is solid at 3.2/5, though slightly below the category average. Music streaming scores 2.8/5, above average but only mixed in absolute terms. At this price point, buyers should consider alternatives. The Rexton Reach R-Li T80 at Costco scores 4.58/5 in the same price range, while lower-priced options like the Lexie B3 (4.76/5) offer stronger overall performance. The Jabra Enhance Pro 20 may suit users who prioritize own-voice comfort and feedback stability over challenging listening environments, but those needing robust noise handling should explore other options.

The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates consistent strength across multiple performance areas. Speech in quiet scored a solid 4.0/5, sitting 0.65 points above the category average. Speech in noise performance, while above the category average by 0.25 points, remains mixed in absolute terms at 2.2/5—a common challenge across prescription devices. Feedback handling is a standout feature, achieving a perfect 5.0/5 and exceeding the already-high category average. Own-voice comfort scores a solid 3.2/5, running 0.45 points above the category average, which suggests good occlusion management. Music streaming performs solidly at 3.0/5, also above average for the category by 0.36 points. The device supports both iPhone and Android streaming along with hands-free functionality. Professional tuning yields meaningful improvement, with the normalized score increasing from 4.0/5 to 4.5/5. Buyers seeking top-tier performance in this price range should note that competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) scored higher in our testing. The Pure C&G IX may suit those who prioritize reliable feedback control and balanced everyday performance over maximum speech-in-noise capability.